Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Lysa, S."'
Autor:
Lysa S. Remy, Juliana Scherer, Luciano Guimarães, Hilary L. Surratt, Steven P. Kurtz, Flavio Pechansky, Felix Kessler
Publikováno v:
Trends in Psychiatry and Psychotherapy, Iss 0 (2017)
Abstract Background This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers. Method Th
Externí odkaz:
https://doaj.org/article/9a19383a264d4e1dad008258034ddb04
Autor:
Galkin, A., Yemchenko, I., Lysa, S., Tarasiuk, M., Chortok, Yuliia Volodymyrivna, Khvesyk, Y.
The development of the retail market in Ukraine and in the world requires the improvement of methods and models of effective interaction of supply and demand in the supply chain for the purchase of goods of daily demand. The article presents an integ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2001::89b9e3077f3dc63ca77c57a7f1c8c5c6
https://essuir.sumdu.edu.ua/handle/123456789/89558
https://essuir.sumdu.edu.ua/handle/123456789/89558
Autor:
Kochubei, D. V., Lysa, S. S.
Publikováno v:
Scientific Bulletin of Polissia. 2018, Vol. 13 Issue 1,Part2, p170-174. 5p.
Autor:
Remy, Lysa S.1 (AUTHOR) lysaremy@gmail.com, Buttram, Mance E.2,3 (AUTHOR), Kurtz, Steven P.4 (AUTHOR), Surratt, Hilary L.5,6 (AUTHOR), Pechansky, Flavio7 (AUTHOR)
Publikováno v:
Journal of Psychoactive Drugs. Nov/Dec2017, Vol. 49 Issue 5, p420-426. 7p.
Autor:
Remy, Lysa S.1 lysaremy@gmail.com, Scherer, Juliana1, Guimarães, Luciano1, Surratt, Hilary L.2, Kurtz, Steven P.3, Pechansky, Flavio1, Kessler, Felix1
Publikováno v:
Trends in Psychiatry & Psychotherapy. Oct-Dec2017, Vol. 39 Issue 4, p239-246. 8p.
Autor:
Craig C. Earle, Lysa S. Magazu, Lisa C. Richardson, Bridget A. Neville, Christopher R. Friese, Gregory A. Abel
Publikováno v:
Leukemia & Lymphoma. 50:392-400
Increased attention to timely diagnosis motivated us to study 5483 patients diagnosed with multiple myeloma using Medicare claims linked to tumor registries in the Surveillance, Epidemiology and End Results programme. We calculated the time between i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8bb8b6d2370c7ad2cef60ff8c8cb89
https://doi.org/10.1080/10428190902741471
https://doi.org/10.1080/10428190902741471
Autor:
Christopher R. Friese, Lysa S. Magazu, Nathanael D. Hevelone, Bridget A. Neville, Gregory A. Abel, Craig C. Earle, Jennifer R. Brown, Lisa C. Richardson
Publikováno v:
Cancer. 117(7)
BACKGROUND: Little is known about the patterns of care relating to the diagnosis of chronic lymphocytic leukemia (CLL), including the use of modern diagnostic techniques such as flow cytometry. METHODS: The authors used the SEER-Medicare database to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f38f40a64799ef27073a63562da1861
https://pubmed.ncbi.nlm.nih.gov/21425148
https://pubmed.ncbi.nlm.nih.gov/21425148
Autor:
Juan Jaime De Zengotita, Craig C. Earle, Lysa S. Magazu, Lisa C. Richardson, Maria E. Fernandez, Christopher R. Friese, Gregory A. Abel
Publikováno v:
Leukemialymphoma. 49(7)
To better understand the extent of diagnostic and referral delays from primary care providers (PCPs) for chronic hematologic malignancies, causes of these delays, and their possible effects on cancer outcomes, an extensive review of the literature wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2530b27a146a1dbd43a23ae03a4d9f4a
https://pubmed.ncbi.nlm.nih.gov/18604724
https://pubmed.ncbi.nlm.nih.gov/18604724
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gregory A. Abel, Lysa S. Magazu, Lisa C. Richardson, Craig C. Earle, Christopher R. Friese, Bridget A. Neville
Publikováno v:
Blood. 114:1369-1369
Abstract 1369 Poster Board I-391 Background: Timeliness of diagnosis is a quality of care measure endorsed by the Institute of Medicine. Clinical outcomes for patients with chronic myelogenous leukemia (CML) are better when tyrosine kinase inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70f0e4de9a210d87826834e57582ffc3
https://doi.org/10.1182/blood.v114.22.1369.1369
https://doi.org/10.1182/blood.v114.22.1369.1369